Article

Blood, Lung Cancer Drug Approvals Highlight AJPB Week in Review

Author(s):

AJPB staff

Top articles of the week from The American Journal of Pharmacy Benefits.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Pharmacist and patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Gardasil vaccine | Image Credit: © wisely - stock.adobe.com
August 16th 2025

Study Finds Widespread Gaps in Knowledge About HPV and Its Link to Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 16th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists
August 16th 2025

Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists

Alana Hippensteele, Lead Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 16th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
According to this online tool, this medication will work best. Shot of a pharmacist using her digital tablet while working in a isle. | Image Credit: Nikish Hiraman/peopleimages.com | stock.adobe.com
August 16th 2025

Leveraging Pharmacy Expertise and Data Systems to Meet EOM Benchmarks

Alana Hippensteele, Lead Editor
Prague,Czech republic-June 17 2024: Jardiance box of medication with Empagliflozin active substance by Boehringer Ingelheim,used for treatment of Type 2 diabetes,Heart failure,Hyperglycemia - Image credit: Semi | stock.adobe.com
August 16th 2025

A Few Key Points Can Guide SGLT2 Inhibitor Management

Jeannette Y. Wick, MBA, RPh, FASCP